# Brasserie Maltco Inc. · 66-41 · CANADA — FDA import alert red lists: firms subject to detention without physical examination

For Brasserie Maltco Inc. · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product is Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade; product code is 29 B - - 06 Soft Drink, Imitation Fruit Flavored, Carbonated | 29 B - - 60 Soda Water, Carbonated | 29 B - - 60 Soda Water, Carbonated | 29 B - - 99 Carbonated Soft Drink, N.E.C. | 29 B - - 99 Carbonated Soft Drink, N.E.C. | 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. | 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - -- Patent Medicines, Etc | 66 V - - -- Patent Medicines, Etc; date published is 12/12/2023; address is 1750 Rue Du Perigord , Quebec, Quebec CANADA, verified against its source on 2026-09-16.

- **Firm:** Brasserie Maltco Inc. _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** CANADA _(verified: appears in the quote below)_
- **Address:** 1750 Rue Du Perigord , Quebec, Quebec CANADA _(verified: appears in the quote below)_
- **Date published:** 12/12/2023 _(verified: appears in the quote below)_
- **Product code:** 29 B - - 06 Soft Drink, Imitation Fruit Flavored, Carbonated | 29 B - - 60 Soda Water, Carbonated | 29 B - - 60 Soda Water, Carbonated | 29 B - - 99 Carbonated Soft Drink, N.E.C. | 29 B - - 99 Carbonated Soft Drink, N.E.C. | 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. | 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - -- Patent Medicines, Etc | 66 V - - -- Patent Medicines, Etc _(verified: each item appears in the quote below)_
- **Product:** Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Pink Lemonade | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Original Flavor | Mind Blow Energy Drink Pink Lemonade _(verified: each item appears in the quote below)_
- **FDA notes:** Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. | Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. _(verified: each item appears in the quote below)_

## What the source says

> Brasserie Maltco Inc. Date Published : 12/12/2023 1750 Rue Du Perigord , Quebec, Quebec CANADA 29 B - - 06 Soft Drink, Imitation Fruit Flavored, Carbonated Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 B - - 60 Soda Water, Carbonated Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 B - - 60 Soda Water, Carbonated Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Original Flavor Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 B - - 99 Carbonated Soft Drink, N.E.C. Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Original Flavor Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 B - - 99 Carbonated Soft Drink, N.E.C. Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Original Flavor Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 29 S - - 99 Carbonated Water (Nonmedicinal), N.E.C. Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Original Flavor Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 66 V - - -- Patent Medicines, Etc Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Original Flavor Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application. 66 V - - -- Patent Medicines, Etc Date Published: 12/12/2023 Desc: Mind Blow Energy Drink Pink Lemonade Notes: Product appears to be new drugs as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p), because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling. There is no evident basis under the FD&C Act under which this product would be legally marketed without an approved application. Under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), a new drug may not be legally marketed in the United States without an FDA-approved new drug application.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).